Profil
Christopher Wick worked as a Regional Director-Sales at Alexion Pharmaceuticals, Inc. from 2018 to 2022.
He also worked as an Executive Director & Head-Sales US Region at RELIEF THERAPEUTICS Holding SA. Mr. Wick completed his undergraduate degree from New Mexico State University.
Anciens postes connus de Christopher Wick
| Sociétés | Poste | Fin |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2022 |
| RELIEF THERAPEUTICS HOLDING SA | Sales & Marketing | - |
Formation de Christopher Wick
| New Mexico State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Health Technology |
| Entreprise privées | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
